Inn

IMI launches $319M 8th call for proposals

Tuesday, December 18, 2012 10:41 AM

The Innovative Medicines Initiative (IMI), the world’s largest public-private partnership in health, is launching its eighth call for proposals. With a total budget of $319 million ($188 million cash from IMI, plus a $131 million in-kind contribution from participating EFPIA companies), the projects resulting from this call will tackle some of the biggest challenges in health research.

More... »

Roche, IMI launch StemBANCC partnership for stem cells as research tools

Wednesday, December 5, 2012 02:03 PM

Switzerland-based Roche and the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients, have launched StemBANCC, a new academic–industry partnership that unites 10 pharmaceutical companies and 23 academic institutions.

More... »

FDA, new MDIC to develop regulatory science to speed access to medical devices

Monday, December 3, 2012 11:48 AM

The FDA has become part of the first public-private partnership to promote medical device regulatory science with a focus on speeding the development, assessment and review of new medical devices.

More... »

Insmed appoints Andrew Drechsler as CFO

Thursday, November 8, 2012 02:49 PM

Insmed, a biopharmaceutical company focused on inhaled therapeutics for serious lung diseases, has appointed Andrew Drechsler to the position of chief financial officer.

More... »

Aclaris raises $21M in Series A Financing

Thursday, October 25, 2012 07:30 AM

Aclaris Therapeutics, a privately held specialty pharmaceutical company focused on dermatological therapeutics, has secured $21 million in Series A financing.

More... »

Innova, Goodmark Medical to set up international operations in Scotland

Wednesday, October 3, 2012 02:58 PM

Innova Partnerships, a life science investment and partnering company based in Boston and Scotland, is working Goodmark Medical of Longwood, Fla., to help them expand into international markets.

More... »

10 pharmas form nonprofit TransCelerate to accelerate R&D of new medicines

Wednesday, September 19, 2012 02:46 PM

Ten biopharmaceutical companies have formed a non-profit organization, TransCelerate BioPharma, to accelerate the development of new medicines. Participants include Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi.

More... »

Medicyte coordinates E.U.-funded collaboration on biomimetic bioartificial liver

Tuesday, July 3, 2012 01:57 PM

Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa have launched a European-wide project, the Re-liver Consortium, aimed to design a biomimetic bioartificial liver.

More... »

Pfizer’s Karen Bien elected to board of SAFE-BioPharma

Friday, June 29, 2012 09:57 AM

Karen Bien, director of business technology on Pfizer’s acquisition, collaboration and divestiture team, has been elected to the board of directors of SAFE-BioPharma Association, the strategic non-profit collaboration that developed and manages the global SAFE-BioPharma digital identity and digital signature standard for the life science and healthcare sectors.

More... »

ExecuPharm expands to U.K. and Argentina

Thursday, June 21, 2012 02:49 PM

ExecuPharm, a staffing and functional service providers (FSP) specializing solely in the clinical research industry, recently expanded its locations to include Europe and Latin America.

More... »